Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children

Chinese Medical Journal

Volumn 122, Issue 10, 2009, Pages 1157-1161

  Chen, Zhuang Gui ^a   Li, Ming ^a   Chen, Yan Feng ^a   Ji, Jing Zhi ^a   Li, Ya Ting ^a   Chen, Wei ^a   Chen, Fen Hua ^a   Chen, Hong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bronchial asthma; Children; Immunotherapy; Interleukin 13; Pulmonary function tests

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON; HOUSE DUST ALLERGEN; INTERLEUKIN 13; INTERLEUKIN 4;

ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; CHILD; CHILD CARE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SPECIFICITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOTHERAPY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW;

ADOLESCENT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CHILD; CHILD, PRESCHOOL; DERMATOPHAGOIDES PTERONYSSINUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOTHERAPY; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-4; MALE;

EID: 68249139760     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.10.008     Document Type: Article

References (25)

1. Bergeron C, Boulet LP. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest 2006; 129: 1068-1087.
2. Blumberga G, Groes L, Haugaard L, Dahl R. Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics. Allergy 2006; 61: 843-848.
3. Broide D. New perspectives on mechanisms underlying chronic allergic inflammation and asthma in 2007. J Allergy Clin Immunol 2008; 122: 475-480.
4. Sime PJ, O'Reilly KM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol 2001; 99: 308-319.
5. Pneumatology Group of Pediatrics Branch of Chinese Medical Association. Children Asthma Prevention and Cure Routine. Chin J Pediatr (Chin) 2004; 42: 100-104.
6. Wang HY, Lin XP, Hao CL, Zhang CQ, Sun BQ, Zheng JP, et al. Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients. Chin J Tuberc Respir Dis (Chin) 2006; 29: 679-687.
7. Wang ZL. New aspects in the treatment of asthma: targeted therapy. Chin Med J 2008; 121: 640-648.
8. Sun YC, Chu HW. Do neutrophils actively participate in airway inflammation and remodeling in asthma? Chin Med J 2004; 117: 1739-1742.
9. Zhang WX, Li CC. Airway remodeling and bronchial asthma in children. Chin J Pediatr (Chin) 2006; 44: 632-663
10. Wang ZL. Research on airway inflammation: present status in Mainland China. Chin Med J 2005; 118: 1007-1014.
11. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354: 1985-1997.
12. Shaikh WA. Immunotherapy vs inhaled budesonide in bronchial asthma: an open, parallel, comparative trial. Clin Exp Allergy 1997; 27: 1279-1284.
13. Haahtela T. Lung function decline in asthma and early intervention with inhaled corticosteroids. Chest 2006; 129: 1405-1406.
14. Malavia NK, Mih JD, Raub CB, Dinh BT, George SC. IL-13 induces a bronchial epithelial phenotype that is profibrotic. Respir Res 2008; 9: 27.
15. Saito A, Okazaki H, Sugawara I, Yamamoto K, Takizawa H. Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int Arch Allergy Immunol 2003; 132: 168-176.
16. Camoretti-Mercado B, Solway J. Transforming growth factor-β1 and disorders of the lung. Cell Biochem Biophys 2005; 43: 131-148.
17. Wen FQ, Kohyama T, Liu XD, Zhu YK, Wang H, Kim HJ, et al. Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma. Am J Respir Cell Mol Biol 2002; 26: 484-490.
18. Du YC, Xu JY, Zhang SJ. Effects of angiotensin II receptor antagonist on expression of collagen III, collagen V, and transforming growth factor beta1 in the airway walls of sensitized rats. Chin Med J 2004; 117: 908-912.
19. Ramos-Barbon D, Ludwig MS, Martin JG. Airway remodeling: lessons from animal models. Clin Rev Allergy Immunol 2004; 27: 3-21.
20. Laporte JC, Moode PE, Baraldo S, Jouvin MH, Church TL, Schwartzman IN, et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 2001; 164: 141-148.
21. Morcillo EJ, Cortijo J. Mucus and MUC in asthma. Curr Opin Pulm Med 2006; 12: 1-6.
22. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998; 81: 401-405.
23. Theodoropoulos DS, Lockey RF. Allergen immunotherapy: guidelines, update, and recommendations of the World Health Organization. Allergy Asthma Proc 2000; 21: 159-166.
24. Rebordão M, Delgado L, Pinto H, Remédios A, Taborda-Barata L. Specific immunotherapy effect on peripheral blood T1/T2 lymphocytes in atopic patients. Rev Port Pneumol 2006; 12: 107-130.
25. Kiwamoto T, Ishii Y, Morishima Y, Yoh K, Maeda A, Ishizaki K, et al. Transcription factors T-bet and GATA-3 regulate development of airway remodeling. Am J Respir Crit Care Med 2006; 174: 142-151.